, a non-fermentative, ubiquitous, gram-negative aerobic bacterium, is associated with high mortality rates, particularly in immunocompromised or debilitated patients. The prevalence rate of ICU-acquired pneumonia episodes caused by this microorganism has been found to be 2%. has been identified as one of the top 10 microorganisms responsible for such infections in EU/EEA countries.
View Article and Find Full Text PDFThe SARS-CoV-2 pandemic caused an increase in intensive care unit (ICU) hospitalizations with a rise in morbidity and mortality; nevertheless, there is still little evidence on the impact of the pandemic on antibiotic resistance in ICUs. This is a retrospective, monocentric epidemiological study. The aim of the study was to describe and analyze the impact of the SARS-CoV-2 pandemic on ICU bacterial resistance patterns.
View Article and Find Full Text PDFErysipelothrix rhusiopathiae is a Gram-positive bacillus that is rarely reported as a causative agent of infections in humans. Human cases in most instances present as localized or generalized skin infections. Invasive infections are exceptionally described and septic forms are usually associated with endocarditis.
View Article and Find Full Text PDFThis clinical driven report describes the unexpected detection of a multidrug resistant (MDR) Streptococcus pneumoniae strain. Italy is usually considered a country characterized by a low prevalence of MDR S. pneumoniae.
View Article and Find Full Text PDFErysipelothrix rhusiopathiae is a Gram-positive bacillus that is infrequently responsible for infections in humans. Most human cases present as localized or generalized cutaneous infections. An invasive septic form, usually associated with endocarditis, has rarely been described.
View Article and Find Full Text PDFTyphoid fever due to multidrug-resistant (MDR) Salmonella typhi has been extensively reported. We present an imported case (from Bangladesh) of typhoid fever with typhoid hepatitis due to an MDR S typhi strain with clinically delayed response or reduced susceptibility to ceftriaxone. The relevant clinical and public health implications are discussed.
View Article and Find Full Text PDF